Cleo Diagnostics (ASX:COV) Marketable Securities : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Cleo Diagnostics's Marketable Securities for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Cleo Diagnostics Marketable Securities Historical Data

The historical data trend for Cleo Diagnostics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Marketable Securities Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Marketable Securities

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Marketable Securities	-	-	-

Cleo Diagnostics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Cleo Diagnostics (ASX:COV) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Cleo Diagnostics Marketable Securities Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines